FindTrial
Sign In

CardioFlux

DEVICE7 trials

Sponsors

Genetesis Inc.

Conditions

Acute Coronary SyndromeAcute Myocardial InfarctionAcute Myocardial InjuriesAnginaCoronary Allograft Vasculopathy (CAV)Coronary Microvascular DiseaseCoronary Microvascular DysfunctionEndocrine Disorder

Unknown Phase

Mason Heart Study With MCG
SuspendedNCT04732975
Genetesis Inc.Acute Myocardial Injuries
Start: 2020-12-14End: 2024-06-30Target: 250Updated: 2023-02-23
Acute Coronary Syndrome CardioFlux TM Study (ACCMED)
CompletedNCT04739267
Genetesis Inc.Acute Myocardial Injuries
Start: 2021-01-27End: 2023-03-03Updated: 2023-05-11
Magnetocardiography Endocrine Registry
SuspendedNCT04739254
Genetesis Inc.Endocrine Disorder
Start: 2020-12-14End: 2030-05-01Target: 250Updated: 2023-10-12
Genetesis Accelerated Registry
SuspendedNCT05051228
Genetesis Inc.Acute Coronary Syndrome, Acute Myocardial Infarction
Start: 2021-01-27End: 2024-07-31Target: 500Updated: 2023-02-23
MCG as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction
CompletedNCT05150054
Genetesis Inc.Coronary Microvascular Dysfunction, Ischemic Non-Obstructive Coronary Artery Disease
Start: 2022-01-14End: 2023-07-30Updated: 2023-08-31
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
NCT05751915
Genetesis Inc.Coronary Allograft Vasculopathy (CAV)
Start: 2023-05-23End: 2024-01-30Target: 40Updated: 2023-07-11
MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
CompletedNCT06212466
Genetesis Inc.Angina, Coronary Microvascular Disease, Ischemic Heart Disease +1
Start: 2024-06-03End: 2025-04-15Updated: 2025-07-10